Navigation Links
US Biologics Market
Date:12/8/2011

p>Study coverage

Details on these and other findings are contained in a new industry study, Biologics, which presents historical demand data (2000, 2005, 2010) plus forecasts for 2015 and 2020 by product and application. This study also considers market environment factors, evaluates company market share and profiles US industry competitors.

TABLE OF CONTENTS

INTRODUCTION ix

I. EXECUTIVE SUMMARY 1

II. MARKET ENVIRONMENT 4

General 4

Demographic Patterns 5

Macroeconomic Outlook 9

Healthcare Trends 12

National Health Expenditures 13

Pharmaceutical Supply & Demand 17

Pharmaceutical Shipments by Therapeutic Class 18

Patient Activity 20

Medical Conditions 23

Acute Conditions 26

Chronic Conditions 26

Animal Health Industry Outlook 28

Technological Overview of Biologics 31

Recombinant DNA Biologics 32

Biosimilars 33

Regulation 36

Regulation of Human Biologic Therapies 36

Regulation of Biosimilar Products 39

Regulation of Biologics Research & Testing Products 40

Regulation of Animal Biologics 41

III. PRODUCTS 42

General 42

Demand by Type 43

Monoclonal Antibodies 46

Cancer Treatment 49

Rheumatoid Arthritis 50

Macular Degeneration 51

Psoriasis 52

Infectious Disease 53

Other Applications 53

Vaccines & Toxoids 54

Vaccines for Human Health 56

Routine Immunizations 57

Influenza 58

Therapeutic Vaccines 58

Other Vaccines 59

Animal Vaccines 60

Hormones 60

Insulin 62

Human Growth Hormone 64

Teriparatide 66

Follicle-Stimulating Hormone 66

Estrogen 67

Calcitonin 68

Thyrotropin 68

Corticotropin 69

Other Hormones 69

Growth Factors 70

Erythropoietins 72

Colon
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
2. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
3. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
4. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
5. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
6. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
7. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
8. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
9. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
10. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
11. CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... ANGLETON, Texas, June 2, 2011 Benchmark Electronics, Inc. ... manufacturing provider, announced today that a product it helped ... Design Excellence Awards. The Avedro Vedera KXS ... Design Excellence Award in the Radiological and Electromechanical Devices ...
... June 2, 2011 Pharmacy Choice and Access Now ... pharmacists across the nation and Texas, committed to preserving ... of Senate Bill 7 (SB 7) in the current ... provide many necessary protections for Texans and their community ...
Cached Medicine Technology:Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner in the Radiological and Electromechanical Devices Category 2Pharmacy Choice and Access Now Coalition Urges Passage of Senate Bill 7 During Texas Legislature's Special Session 2
(Date:4/18/2014)... article published online in The Gerontologist ... music is associated with a decrease in anxiety about ... of control over their lives. In particular, listening to ... about death and an increase in sense of control. ... women and men, and individuals of both low- and ...
(Date:4/18/2014)... April 18, 2014) Benaroya Research Institute at ... how blocking a particular molecule in metastatic breast cancer ... number of lung metastases. BRI scientists have found in ... shrink tumors by 60 - 80 percent and can ... lung. The $1.8 million five-year grant comes from the ...
(Date:4/18/2014)... lead to potential new treatments for breaking the cycle ... Fibrosis, or scarring, is a hallmark of the disease, ... lead to serious organ damage and, in some cases, ... on findings made by Swati Bhattacharyya, PhD, research assistant ... specific protein plays in promoting fibrosis. , "Our ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2
... Sept. 24 Speaker Nancy Pelosi,issued the following ... fiscal responsibility. Documents are available on the,Administration,s record ... to meeting our national priorities -- in a ... spending:, "The President has no credibility on ...
... Care for Urgent Health Problems Report Highest Satisfaction When ... Walk-in Clinics , Patient satisfaction with after-hours care for ... own family physician or their physicians after-hours clinic, compared ... health advisory services. According to a survey of 1,227 ...
... approximately 36,000 people in the United States, most over ... influenza vaccine in older seniors. Randomized, placebo-controlled clinical trials ... how well the vaccine can prevent death in this ... October issue of The Lancet Infectious Diseases, now available ...
... host more than 200 physicians and emergency medicine technicians ... Conference, Sept. 26-28. Those attending will learn how to ... circumstances encountered in the wilderness., The emergency medical system ... New York City and the 2005 Hurricane Katrina disaster ...
... Data Package Provided in NDA Demonstrates ... Once-Daily Tramadol Formulation, LAVAL, QC, Sept. 24 /PRNewswire-FirstCall/ ... is has requested a meeting with the U.S.,Food and ... for its once-daily formulation of tramadol. Based on,additional analysis ...
... Findings Raise Serious Concerns for Massive, Pending Carlyle Group Takeover ... ... on Carlyle to Ensure Buyout Doesn,t Worsen Care, WASHINGTON, Sept. 24 ... how cuts to staffing and,operations at nursing homes bought by private equity ...
Cached Medicine News:Health News:September/October 2007 Annals of Family Medicine tip sheet 2Health News:September/October 2007 Annals of Family Medicine tip sheet 3Health News:September/October 2007 Annals of Family Medicine tip sheet 4Health News:September/October 2007 Annals of Family Medicine tip sheet 5Health News:September/October 2007 Annals of Family Medicine tip sheet 6Health News:September/October 2007 Annals of Family Medicine tip sheet 7Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 2Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 3Health News:New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes 2Health News:New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursing Homes 3
For the determination of urea nitrogen in human serum....
For the quantitative determination of Urea Nitrogen in serum. Linearity: 80 mg/dl. Reaction measured at 340 nm....
For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
... The 1100 Spectrophotometers ... economical. Great for use ... laboratories, including educational, clinical, ... Options include COD vial ...
Medicine Products: